← FDA Drug Approvals (Drugs@FDA)
LEVOMILNACIPRAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS USA INC · Approved 2023-01-12
Drug application
- FDA Application #
ANDA210857- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LEVOMILNACIPRAN
- Generic name
- Levomilnacipran
- Active ingredients
- LEVOMILNACIPRAN
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- ZYDUS PHARMS USA INC
- First approval
- 2023-01-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown